Trombosis espleno-portal no cirrótica, no tumoral y policitemia vera: una asociación poco frecuente
Resumen
Palabras clave
Referencias
Spivak J. Polycythemia Vera and Other Myeloproliferative Neoplasm. En: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison´s Principles of Internal Medicine. 19 ed. NewYork:McGraw-Hill;2015. p. 672-8.
Tefferi A. Policitemia Vera, trombocitopenia esencial y mielofibrosis primaria. En: Goldman L, Schafer A. Goldman-Cecil Medicine. 25 ed. Philadelphia:Elsevier Saunders; 2016. p. 244-30.
Kaushansky K. Hematopoyesis y factores de crecimientos. En: Goldman L, Schafer A. Goldman-Cecil Medicine. 25 ed. Philadelphia:Elsevier Saunders;2016. p. 237-44.
Armitage J, Bierman P. Aproximación al paciente con adenopatias y esplenomegalia. En: Goldman L, Schafer A. Goldman-Cecil Medicine. 25 ed. Philadelphia:Elsevier Saunders; 2016. p. 567-89.
Benz EJ. Disorders of Hemoglobin. En: Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL, Loscalzo J. Harrison´s Principles of Internal Medicine 19 ed. New York: McGraw-Hill;2015. p. 178-83.
Gisslinger H, Gotic M, Holowiecki J, Penka M, Thiele J, Kvasnicka HM, et al. Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial. Blood. 2013;121(10):1720-8.
Pardanani A. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Am J Hematol. 2015;90(3):250-62.
Llop E, Seijo S. Treatment of non-cirrhotic, non-tumoral portal vein trombosis. Gastrohep. 2016;39(6):403-10.
Zandrino F, Musante F, Gallesio I, Benzi L. Assessment of patients with acute mesenteric ischaemia: multislice computed tomography signs and clinical performance in a group of patients with surgical correlation. Minerva Gastroenterol Dietol. 2006;52(3):317-25.
Orr DW, Harrison PM, Devlin J, Karani JB, Kane PA, Heaton ND, et al. Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long-term follow-up. Clin Gastroenterol Hepatol. 2007;5(1):80-6.
Squizzato A, Romualdi E, Middeldorp S. Antiplatelet drugs for polycythaemia vera and essential thrombocythaemia. Cochrane Database Syst Rev. 2008;16(2):CD006503.
Harrison C, Kiladjian JJ, Al-Ali HK, Gisslinger H, Waltzman R, Stalbovskaya V, et al. JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. N Engl J Med. 2012;366(9):787-98.
Enlaces refback
- No hay ningún enlace refback.
FINLAY EN:
![latindex_75 latindex_75](https://ucarecdn.com/2e380558-40d6-4109-b975-bf90fb9bb211/latindex_75.jpg)
![medigraphy_75 medigraphy_75](https://ucarecdn.com/7ff03a04-81ad-482c-b62f-ea45c6725ddb/medigraphy_75.jpg)
![](https://ucarecdn.com/e85a1c2a-abf0-466c-8990-519ccb915a44/Hinari.jpeg)
![](https://ucarecdn.com/e6eef6f0-e9b0-4d6e-bcf3-3bf40513af54/scielo_cuba2.jpeg)
![](https://ucarecdn.com/8a7d1079-59b8-4c3e-b3e6-f96b5b890fda/Redib.jpeg)
![](https://ucarecdn.com/321d99a3-2be7-4cf5-b603-619de268f3da/Thomson_Reuter.jpeg)
FINLAY CERTIFICADA POR:
Esta revista "no aplica" cargos por publicación en ninguna etapa del proceso editorial.
Dirección postal: Calle 51A y Avenida 5 de Septiembre Cienfuegos, Cuba Código postal: 55100.
http://www.revfinlay.sld.cu
Telefono: +53 43 516602. Telefax: +53 43 517733.
amgiraldoni@infomed.sld.cu
ISSN: 2221-2434
RNPS: 5129